Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 122, Issue 1, 2005, Pages 61-65

  Polachek, Hana ^a   Holcberg, Gershon ^b   Sapir, Gadi ^b   Tsadkin Tamir, Marina ^a   Polachek, Joseph ^a   Katz, Miriam ^b   Ben Zvi, Zvi ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Ciprofloxacin; Levofloxacin; Ofloxacin; Placental transfer

Indexed keywords

BOVINE SERUM ALBUMIN; CIPROFLOXACIN; GLUCOSE; LEVOFLOXACIN; OFLOXACIN; PHENAZONE;

ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DIFFUSION; DRUG DISTRIBUTION; FETOPLACENTAL UNIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; STEADY STATE;

EID: 24644509835     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.11.031     Document Type: Article

References (25)

1. V. Ganapathy, P.D. Prasad, M.E. Ganapathy, and F.H. Leibach Placental transporters relevant to drug distributon across the maternal-fetal interface J Pharmacol Exp Ther 294 2000 413 420
2. B.G. Katzung Basic and clinical pharmacology Fluoroquinolones 2001 797 802
3. H. Giamarellou, E. Kolokythas, G. Petrikkos, J. Gazis, D. Aravantinos, and F. Sfikakis Pharmacokinetics of three newer quinolones in pregnant and lactating women Am J Med 87 Suppl. 5A 1989 49s 51s
4. C. Forster, K. Kociok, M. Shakibaei, H-J. Merker, and R. Stahlmann Quinolone-induced cartilage lesions are not reversible in rats Arch Toxicol 70 1996 474 481
5. R. Stahlmann, U. Zippel, C. Forster, R. Schwabe, M. Shakiebaei, and H-J. Merker Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats Antimicrob Agent Chemother 42 1998 1470 1475
6. J. Dancis Why perfuse the human placenta H. Schneider J. Dancis In vitro perfusion of human placental tissue 1985 Karger Basel 1 4
7. H. Schneider, and A. Huch Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation H. Schneider J. Dancis In vitro perfusion of human placental tissue 1985 Karger Basel 40 47
8. G. Holcberg, O. Sapir, M. Tsadkin-Tamir, and M. Huleihel Lack of interaction of digoxin and P- glycoprotein inhibitors, guinidine and verapamil in human placenta in vitro Eur J Obstet Gynecol Reprod Biol 109 2003 133 137
9. M. Huleihel, A. Alaa, and S. Olga Perfusion of human term placentas with lipopolysaccharide did not affect the capacity of the fetal and maternal tissues to produce interleukin-10 Eur Cytokine Netw 14 4 2003 229 233
10. R.K. Miller, P.J. Wier, D. Maulik, and P. Anthony Human placenta in vitro: characterization during 12 h of dual perfusion H. Schneider J. Dancis In vitro perfusion of human placental tissue 1985 Karger Basel 77 84
11. J.-C. Challier Criteria for evaluating perfusion experiments and presentation of results H. Schneider J. Dancis In vitro perfusion of human placental tissue 1985 Karger Basel 32 39
12. H. Schneider, M. Panigel, and J. Dancis Transfer across the human placenta of antipyrine, sodium and leucine Am J Obstet Gynecol 144 1972 822 828
13. 2 O in the isolated dually in vitro perfused lobe of the human placenta In vitro perfusion of human placental tissue 1985 Karger Basel pp. 114-123
14. M. Gips, S. Barel, M. Bridzy, and S. Soback Detection of fluoroquinolone residues in milk Proceedings of the Third IDF International Mastitis Seminar Israel, May 1995
15. L. Shargel, W. Cheung, and A. Yu High-pressure liquid chromatographic analysis of antipyrine in small plasma samples J Pharm Sci 68 1979 1052 1054
16. M. Murata, I. Tamai, H. Kato, O. Negata, H. Kato, and A. Tsuji Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier J Pharmacol Exp Ther 290 1999 51 57
17. I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, and Y. Shima Limited distribution of new quinolone antibacterial agent into brain caused by multiple efflux transporters at the blood-brain barrier J Pharmacol Exp Ther 295 2000 146 152
18. M.E. Cavet, M. West, and N.L. Simons Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells Br J Pharmacol 121 1997 1567 1578
19. S. Lowes, and N.L. Simmons Multiple pathway for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells Br J Pharmacol 135 2002 1263 1275
20. S. Dautrey, K. Felice, A. Petiet, B. Lacour, C. Carbon, and R. Farinotti Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates Br J Pharmacol 127 1999 1728 1734
21. G. Holcberg, M. Tsadkin-Tamir, O. Sapir, M. Huleihel, M. Mazor, and Z. Ben-Zvi Nev aspects in placental drug transfer Isr Med Assoc J 5 12 2003 873 876
22. N. Utoguchi, M. Magnusson, and K.L. Audus Carrier-mediated transport of monocarboxylic acid in BeWo cell monolayers as a model of the human trophoblast J Pharm Sci 88 1999 1288 1292
23. R. Loebstein, A. Addis, E. Ho, R. Andreou, S. Sages, and A.E. Donnenfeld Pregnancy outcome following gestational exposure to FQ Antimicrob Agent Chemother 42 1998 1336 1339
24. C. Schaefer, E. Amoura-Elefant, T. Vial, A. Ornoy, H. Garbis, and E. Robert Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS) Eur J Obstet Gynecol 69 1996 83 89
25. M. Berkovitch, A. Pastuszak, M. Gazarian, M. Lewis, and G. Koren Safety of the new quinolones in pregnancy Obstet Gynecol 84 1994 535 538